Autoimmune Disorder Clinical Trials

8 recruitingLast updated: June 18, 2026

There are 8 actively recruiting autoimmune disorder clinical trials across 3 countries. Studies span Phase 2, Phase 1, Not Applicable. Top locations include Pittsburgh, Pennsylvania, United States, New York, New York, United States, Ann Arbor, Michigan, United States. Updated daily from ClinicalTrials.gov.


Autoimmune Disorder Trials at a Glance

8 actively recruiting trials for autoimmune disorder are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Phase 2 with 4 trials, with the heaviest enrollment activity in Pittsburgh, New York, and Ann Arbor. Lead sponsors running autoimmune disorder studies include National Institute of Allergy and Infectious Diseases (NIAID), University of Pittsburgh, and Chinese PLA General Hospital.

Browse autoimmune disorder trials by phase

Treatments under study

About Autoimmune Disorder Clinical Trials

Looking for clinical trials for Autoimmune Disorder? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Autoimmune Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Autoimmune Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 1

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

B-cell Mediated Autoimmune Disorders
TG Therapeutics, Inc.100 enrolled8 locationsNCT06680037
Recruiting
Not Applicable

Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting

CancerInfertility, MaleAutoimmune Disorder
University of Pittsburgh10 enrolled1 locationNCT04452305
Recruiting
Not Applicable

Testicular Tissue Cryopreservation for Fertility Preservation

CancerAutoimmune Disorders
University of Pittsburgh1,500 enrolled1 locationNCT02972801
Recruiting
Phase 1Phase 2

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

Systemic Lupus ErythematosusLupusAutoimmune Disorders+2 more
M.D. Anderson Cancer Center47 enrolled2 locationsNCT06434363
Recruiting
Phase 2

Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

Autoimmune Disorders
National Institute of Allergy and Infectious Diseases (NIAID)30 enrolled8 locationsNCT07103746
Recruiting
Phase 1Phase 2

Daratumumab in Primary Antiphospholipid Syndrome

Autoimmune Disorders
National Institute of Allergy and Infectious Diseases (NIAID)22 enrolled8 locationsNCT05671757
Recruiting
Phase 2

Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease

B-cell Mediated Autoimmune DisordersIgG4-related Disease
Chinese PLA General Hospital9 enrolled1 locationNCT07148791
Recruiting

A Single-Dose Safety and Tolerability Placebo Controlled Study of Subcutaneous SCH 900222 in Healthy Volunteers

The use of SCH 900222 for autoimmune disorders.
Schering-Plough32 enrolled1 locationACTRN12609000233224